Keros
is a Massachusetts-based biopharmaceutical company that researches and commercializes novel therapeutics for the treatment of neuromuscular disorders... Read moreKeros
is a Massachusetts-based biopharmaceutical company that researches and commercializes novel therapeutics for the treatment of neuromuscular disorders... Read more
2015
PublicNASDAQKROS
News
Mar 09, 2026
GlobalNewswire
Press Release: Keros : Keros Therapeutics Presents Additional Clinical Data from Its Rinvatercept Program at the 2026 MDA Clinical & Scientific Conference
Mar 06, 2026
Zacks
Keros: Can Keros Therapeutics Rinvatercept Stand Out in the DMD Market?
Mar 05, 2026
Owler
Keros Therapeutics, Inc.: Keros's revenue changed from $246.72M in Sep 2025 to $244.06M in Dec 2025
Mar 05, 2026
Nasdaq
Keros: Keros Therapeutics Reports FY25 Results, Highlights Progress Across Hematology And Muscle Pipeline
Feb 27, 2026
GlobalNewswire
Press Release: Keros : Keros Therapeutics Appoints Charles Newton to its Board of Directors
Feb 18, 2026
Zacks
Keros: Should Investors Buy, Sell or Hold KROS Stock Ahead of Q4 Earnings?
Jan 26, 2026
Zacks
Keros: Is KROS' KER-065 the Next Breakthrough in DMD Space?
Jan 16, 2026
Zacks
Keros: Will KROS Stock's Restructuring Efforts Reap Rewards for Investors?
Dec 22, 2025
Zacks
Keros: Here's Why Keros Therapeutics (KROS) Could be Great Choice for a Bottom Fisher
Dec 12, 2025
Zacks
Keros: What Makes Keros Therapeutics, Inc. (KROS) a Strong Momentum Stock: Buy Now?
Keros Competitors
1
2
3
4
5
6
7
8
9
10